Overexpression and ELISA-based detection of asprosin in cultured cells and mice.

STAR Protoc

Harrington Discovery Institute at University Hospitals, 2103 Cornell Road, Wolstein Research Building 4130, Cleveland, OH 44106, USA; Department of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH 44106, USA. Electronic address:

Published: December 2022

The unreliability of commercial recombinant asprosin preparations and variability between asprosin detection assays have proven to be a bottleneck in experimental interpretation. This protocol describes the use of viral vectors and expression plasmid for overexpression and secretion of human asprosin to achieve sustained elevation of asprosin protein in mice and HEK293T cells without using recombinant proteins. This protocol also includes a sandwich ELISA using anti-asprosin monoclonal antibodies for detection of asprosin in media from cultured cells and in plasma of mice. For complete details on the use and execution of this protocol, please refer to Duerrschmid et al. (2017), Mishra et al. (2021), and Mishra et al. (2022).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568886PMC
http://dx.doi.org/10.1016/j.xpro.2022.101762DOI Listing

Publication Analysis

Top Keywords

detection asprosin
8
cultured cells
8
mishra et al
8
asprosin
6
overexpression elisa-based
4
elisa-based detection
4
asprosin cultured
4
cells mice
4
mice unreliability
4
unreliability commercial
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!